TOMM20 anticorps (AA 25-145)

N° du produit ABIN5776002

Cet anticorps Souris Monoclonal détecte spécifiquement TOMM20 dans WB, IF, ELISA, FACS et ICC. Il présente une réactivité envers Humain.

Aperçu rapide pour TOMM20 anticorps (AA 25-145) (ABIN5776002)

Antigène: TOMM20 (Mitochondrial Import Receptor Subunit TOM20 homolog (TOMM20))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp TOMM20 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)

Clone: AT1B2

Détail du produit anti-TOMM20 anticorps

Épitope: AA 25-145

Fonction: Human TOMM20 antibody

Purification: Purified

Immunogène: Recombinant human Tomm20 (25-145aa) purified from E. coli

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Détails sur TOMM20

Antigène: TOMM20 (Mitochondrial Import Receptor Subunit TOM20 homolog (TOMM20))

Autre désignation: TOMM20

Sujet: Mitochondrial import receptor subunit TOMM20 homolog, also known as TOMM20, belongs to the Tom20 family. The Tom machinery consists of import receptors for the initial binding of cytosolically synthesized preproteins and a general import pore (GIP) for the membrane translocation of various preproteins into the mitochondria. TOMM20 functions as the transit peptide receptor at the surface of the mitochondrion outer membrane and facilitates the movement of preproteins into the TOM40 translocation pore.

NCBI Accession: NP_055580

Pathways: Unfolded Protein Response